Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer (IPG590)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 August 2017
Irreversible electroporation for treating prostate cancer (IPG572)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 21 December 2016
Focal therapy using cryoablation for localised prostate cancer (IPG423)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 April 2012
Focal therapy using high-intensity focused ultrasound for localised prostate cancer (IPG424)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 April 2012
Transperineal template biopsy and mapping of the prostate (IPG364)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 October 2010
Intraoperative red blood cell salvage during radical prostatectomy or radical cystectomy (IPG258)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 April 2008
Laparoscopic radical prostatectomy (IPG193)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 November 2006
High dose rate brachytherapy in combination with external-beam radiotherapy for localised prostate cancer (IPG174)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 24 May 2006
Cryotherapy as a primary treatment for prostate cancer (IPG145)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 November 2005
Low dose rate brachytherapy for localised prostate cancer (IPG132)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 July 2005
Cryotherapy for recurrent prostate cancer (IPG119)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 May 2005
High-intensity focused ultrasound for prostate cancer (IPG118)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 March 2005
Irreversible electroporation for treating prostate cancerStatus:Awaiting developmentProgramme:Interventional procedures guidanceExpected publication date: 1 February 2023
Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancerStatus:Awaiting developmentProgramme:Interventional procedures guidanceExpected publication date: 7 February 2023
Focal therapy using high-intensity focused ultrasound for localised prostate cancerStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: 5 April 2023
Irreversible electroporation for treating prostate cancerStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: TBC
Prostate specific membrane antigen (PSMA) radiotherapy for treating advanced prostate cancerStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC